Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Condition(s):Fetal and Neonatal Alloimmune ThrombocytopeniaLast Updated:December 5, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Fetal and Neonatal Alloimmune ThrombocytopeniaLast Updated:December 5, 2023Recruiting
Condition(s):Fetal and Neonatal Alloimmune ThrombocytopeniaLast Updated:September 2, 2020Completed
Condition(s):Fetal and Neonatal Alloimmune ThrombocytopeniaLast Updated:May 10, 2019Completed
Condition(s):Fetal and Neonatal Alloimmune Thrombocytopenia; Long Term Adverse Effects; Neurodevelopmental Abnormality; Intravenous Immunoglobulin Adverse ReactionLast Updated:August 27, 2020Unknown status
Condition(s):Neonatal Thrombocytopenia Isoimmunization Maternal-fetalLast Updated:July 28, 2023Withdrawn
Condition(s):Maternal-Fetal ExchangeLast Updated:August 29, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.